Two neoepitopes generated from TP53 T256fs mutation were computationally predicted (RRPILTIINT for HLA-B*27:05, IINTGRLQW for HLA-C*02:02) and tested for their ability to give rise to functional T cell-mediated immune responses in the tumor host. This evidence concerns the gene TP53 and neoplasm.